DoD Amyotrophic Lateral Sclerosis Research Program Therapeutic Development Award

Post Date

May 27th 2009

Application Due Date

October 15th 2009

Funding Opportunity Number

W81XWH-09-ALSRP-TDA

CFDA Number(s)

12.420

Funding Instrument Type(s)

Cooperative Agreement
Grant

Funding Activity Categories

Science and Technology and other Research and Development

Number of Awards

3

Eligibility Categories

Unrestricted

Funding

• Estimated Total Funding:

  $5000000

• Award Range:

  $None - $None

Grant Description

As the vision of the FY09 ALSRP is to improve treatments for ALS, the Therapeutic Development Award is being offered to support preclinical development of therapeutics for amyotrophic lateral sclerosis (ALS). Investigators are encouraged to undertake preclinical studies of novel and existing agents. The Therapeutic Development Award is restricted to research in ALS. The proposed studies are expected to be empirical in nature and product-driven, but may have a hypothesis-driven approach, provided the focus is on therapeutics. It is anticipated that the agents and/or data generated from these awards will lead to the advancement of therapeutics for ALS. Studies focused on basic science research that will not directly inform therapeutic development do not meet the intent of the award mechanism. Additionally, clinical trials will not be allowed.

Contact Information

• Agency

  Department of Defense

• Office:

  Dept. of the Army -- USAMRAA

• Agency Contact:

  PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
  eReceipt HELP: 301-682-5507; help@cdmrp.org
  

• Agency Mailing Address:

  CDMRP Help Desk

• Agency Email Address:

  cdmrp.pa@amedd.army.mil